Results: 2

Amifostine protects from the peripheral sensory neuropathy induced by oxaliplatin in mice

Braz. j. med. biol. res; 53 (11), 2020
Sensory neuropathy is a dose-limiting side effect of oxaliplatin-based cancer treatment. This study investigated the antinociceptive effect of amifostine and its potential neuroprotective mechanisms on the oxaliplatin-related peripheral sensory neuropathy in mice. Oxaliplatin (1 mg/kg) was injected intra...

Amifostine reduces inflammation and protects against 5-fluorouracil-induced oral mucositis and hyposalivation

Braz. j. med. biol. res; 52 (3), 2019
Oral mucositis (OM) is a common and dose-limiting side effect of cancer treatment, including 5-fluorouracil (5-FU) and radiotherapy. The efficacy of the therapeutic measures to prevent OM is limited and disease prevention is not fully observable. Amifostine is a cytoprotective agent with a described anti...